EN DE
STOCK COMPARISON

Daishin Balance No.8 Special Purpose Acquisition Co. vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Daishin Balance No.8 Special Purpose Acquisition Co. (336570) and Abbott Laboratories (ABT) compare, as of Aug 11, 2026.

As of Aug 11, 2026, Fair Value Calculator sees Daishin Balance No.8 Special Purpose Acquisition Co. as the less overvalued of the two: Daishin Balance No.8 Special Purpose Acquisition Co. trades at KRW 5,330 versus a fair value of KRW 4,322 (-19%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).
Daishin Balance No.8 Special Purpose Acquisition Co.
336570.KQ · KRW · Energy
-19%
upside to fair value
overvalued
PriceKRW 5,330
Fair ValueKRW 4,322
Quality78/100
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$108
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Daishin Balance No.8 Special Purpose Acquisition Co.Abbott Laboratories
Valuation
P/E (TTM)27.7×
P/S (TTM)3.89×
P/B3.36×
EV/EBITDA15.1×
PEG1.47×
1.0%Dividend yield
KRW 50Dividend per share
Profitability
21%Net margin14%
28%Operating margin13%
23%Return on equity12%
14%Return on assets6%
Growth
8%Revenue growth (YoY)8%
24.4%Avg. growth/yr (3Y)0.5%
Avg. growth/yr (5Y)5.1%
Balance & size
0.00×Debt / equity0.19×
$314MMarket cap$175B
mixedGrowth qualityhealthy

Daishin Balance No.8 Special Purpose Acquisition Co. leads: 6 to 1 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Daishin Balance No.8 Special Purpose Acquisition Co.of which business quality 78 · market factors 14 Abbott Laboratoriesof which business quality 66 · market factors 51
ProfitabilityMargins and returns on capital today
80
50
Quality GrowthAre margins and returns improving?
79
47
CashflowEarnings quality: real cash, not paper profit
91
71
Fin. StrengthBalance sheet, leverage, solvency risk
89
80
InvestmentDisciplined investing over empire-building
33
65
Low VolatilityCalm price path (market factor)
37
83
MomentumPrice trend over the last 3–12 months (market factor)
6
40
52W MomentumDistance to the 52-week high (market factor)
2
33
Net IssuanceBuybacks instead of dilution
74
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Daishin Balance No.8 Special Purpose Acquisition Co.

DCF ModelsKRW 12,157
Earnings-BasedKRW 12,138
Dividend DiscountKRW 958
MultiplesKRW 3,624
Asset-BasedKRW 1,188
Growth DCFKRW 13,412
Economic ProfitKRW 7,742
Growth EarningsKRW 14,507

8 of 26 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Daishin Balance No.8 Special Purpose Acquisition Co.
Bear KRW 3,042Fair Value KRW 4,322Bull KRW 17,287
KRW 5,330 = current price (white tick)
Abbott Laboratories
Bear $51.84Fair Value $74.79Bull $94.43
$108 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Daishin Balance No.8 Special Purpose Acquisition Co. · Energy

Quality score78 · Top 25%
Fair value upside-19% · above median

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · below median

Bottom line

As of Aug 11, 2026, Fair Value Calculator sees Daishin Balance No.8 Special Purpose Acquisition Co. as the less overvalued of the two: Daishin Balance No.8 Special Purpose Acquisition Co. trades at KRW 5,330 versus a fair value of KRW 4,322 (-19%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).

Daishin Balance No.8 Special Purpose Acquisition Co. has the higher quality score (78/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.